MUMBAI: Ahmedabad-based Nirma said on Friday the acquisition of Glenmark Life Sciences presents an ideal platform to propel its pharmaceutical business into its next phase of growth. The detergent-to-cement conglomerate entered into an agreement with Glenmark Pharma to buy its subsidiary, GLS, for Rs 5,652 crore on Thursday. With this acquisition, the group will foray into active pharmaceutical ingredient (API) platform and expand its existing presence in pharmaceuticals portfolio consisting of injectables, parentals and ophthalmic products, it said in a statement. GLS is primarily engaged in the development...
MUMBAI: Ahmedabad-based Nirma said on Friday the acquisition of Glenmark Life Sciences presents an ideal platform to propel its pharmaceutical business into its...